Highland Capital Management (Texas)’s Mustang Bio MBIO Stock Holding History

Highland Capital Management (Texas)’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.29M	Buy	+467	New	+$1.33M	0.08%	186

Other funds holding MBIO

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Highland Capital Management (Texas)'s MBIO Position: Q2 2019 in Review

Highland Capital Management (Texas) opened a new position in Mustang Bio (MBIO) in Q2 2019: 467 shares worth $1.29M. The stake represents 0.08% of the portfolio and ranks #186 among its holdings.

55 funds tracked by Wall St. Rank hold MBIO as of Q2 2019.

Highland Capital Management (Texas) held 467 shares of Mustang Bio worth $1.29M as of Q2 2019.
Mustang Bio was a new Highland Capital Management (Texas) position in Q2 2019.
Mustang Bio made up 0.08% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #186 holding.
55 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.